Table S1 from ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors

2026 Open access

Read full text
Authors: Marc Lopez, Emerence Crompot, Emmanuelle Josselin, Anne Farina, Marion Rubis, Rémy Castellano, Joanna Fares, Maria Wehbe, Yves Collette, Emmanuelle Charafe‐Jauffret, Stéphanie Blanchin, François Romagné
+10 more Anikó Pálfí, Torsten Hechler, Andreas M. Pahl, Hatem A. Azim, Florence Lhospice, Émilie Mamessier, François Bertucci, Jack Elands, Xavier Préville, Daniel Olive
DOI: 10.1158/2767-9764.31762010
Cited by: 0

Abstract

Supplementary Table 1 shows apparent affinity of various chimeric mAbs and human HA22 anti-nectin-4 mAbs

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers Radiopharmaceutical Chemistry and Applications

Publication details

Publication date
16 March 2026
Language
EN